Pharmaceuticals

Global Bi-Specific MAbS Market Size, Status and Forecast 2021-2027

SKU ID :QYR-19408944 | Published Date: 27-Oct-2021 | No. of pages: 121

TOC

1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Bi-Specific MAbS Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Catumaxomab 1.2.3 Blinatumomab 1.2.4 Duligotumab 1.2.5 SAR 156597 1.3 Market by Application 1.3.1 Global Bi-Specific MAbS Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Cancer 1.3.3 Autoimmune Diseases 1.3.4 Inflammatory Diseases 1.3.5 Infectious Diseases 1.3.6 Microbial Diseases 1.3.7 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Bi-Specific MAbS Market Perspective (2016-2027) 2.2 Bi-Specific MAbS Growth Trends by Regions 2.2.1 Bi-Specific MAbS Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Bi-Specific MAbS Historic Market Share by Regions (2016-2021) 2.2.3 Bi-Specific MAbS Forecasted Market Size by Regions (2022-2027) 2.3 Bi-Specific MAbS Industry Dynamic 2.3.1 Bi-Specific MAbS Market Trends 2.3.2 Bi-Specific MAbS Market Drivers 2.3.3 Bi-Specific MAbS Market Challenges 2.3.4 Bi-Specific MAbS Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Bi-Specific MAbS Players by Revenue 3.1.1 Global Top Bi-Specific MAbS Players by Revenue (2016-2021) 3.1.2 Global Bi-Specific MAbS Revenue Market Share by Players (2016-2021) 3.2 Global Bi-Specific MAbS Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Bi-Specific MAbS Revenue 3.4 Global Bi-Specific MAbS Market Concentration Ratio 3.4.1 Global Bi-Specific MAbS Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Bi-Specific MAbS Revenue in 2020 3.5 Bi-Specific MAbS Key Players Head office and Area Served 3.6 Key Players Bi-Specific MAbS Product Solution and Service 3.7 Date of Enter into Bi-Specific MAbS Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Bi-Specific MAbS Breakdown Data by Type 4.1 Global Bi-Specific MAbS Historic Market Size by Type (2016-2021) 4.2 Global Bi-Specific MAbS Forecasted Market Size by Type (2022-2027) 5 Bi-Specific MAbS Breakdown Data by Application 5.1 Global Bi-Specific MAbS Historic Market Size by Application (2016-2021) 5.2 Global Bi-Specific MAbS Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Bi-Specific MAbS Market Size (2016-2027) 6.2 North America Bi-Specific MAbS Market Size by Type 6.2.1 North America Bi-Specific MAbS Market Size by Type (2016-2021) 6.2.2 North America Bi-Specific MAbS Market Size by Type (2022-2027) 6.2.3 North America Bi-Specific MAbS Market Size by Type (2016-2027) 6.3 North America Bi-Specific MAbS Market Size by Application 6.3.1 North America Bi-Specific MAbS Market Size by Application (2016-2021) 6.3.2 North America Bi-Specific MAbS Market Size by Application (2022-2027) 6.3.3 North America Bi-Specific MAbS Market Size by Application (2016-2027) 6.4 North America Bi-Specific MAbS Market Size by Country 6.4.1 North America Bi-Specific MAbS Market Size by Country (2016-2021) 6.4.2 North America Bi-Specific MAbS Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Bi-Specific MAbS Market Size (2016-2027) 7.2 Europe Bi-Specific MAbS Market Size by Type 7.2.1 Europe Bi-Specific MAbS Market Size by Type (2016-2021) 7.2.2 Europe Bi-Specific MAbS Market Size by Type (2022-2027) 7.2.3 Europe Bi-Specific MAbS Market Size by Type (2016-2027) 7.3 Europe Bi-Specific MAbS Market Size by Application 7.3.1 Europe Bi-Specific MAbS Market Size by Application (2016-2021) 7.3.2 Europe Bi-Specific MAbS Market Size by Application (2022-2027) 7.3.3 Europe Bi-Specific MAbS Market Size by Application (2016-2027) 7.4 Europe Bi-Specific MAbS Market Size by Country 7.4.1 Europe Bi-Specific MAbS Market Size by Country (2016-2021) 7.4.2 Europe Bi-Specific MAbS Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Bi-Specific MAbS Market Size (2016-2027) 8.2 Asia-Pacific Bi-Specific MAbS Market Size by Type 8.2.1 Asia-Pacific Bi-Specific MAbS Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Bi-Specific MAbS Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Bi-Specific MAbS Market Size by Type (2016-2027) 8.3 Asia-Pacific Bi-Specific MAbS Market Size by Application 8.3.1 Asia-Pacific Bi-Specific MAbS Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Bi-Specific MAbS Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Bi-Specific MAbS Market Size by Application (2016-2027) 8.4 Asia-Pacific Bi-Specific MAbS Market Size by Region 8.4.1 Asia-Pacific Bi-Specific MAbS Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Bi-Specific MAbS Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Bi-Specific MAbS Market Size (2016-2027) 9.2 Latin America Bi-Specific MAbS Market Size by Type 9.2.1 Latin America Bi-Specific MAbS Market Size by Type (2016-2021) 9.2.2 Latin America Bi-Specific MAbS Market Size by Type (2022-2027) 9.2.3 Latin America Bi-Specific MAbS Market Size by Type (2016-2027) 9.3 Latin America Bi-Specific MAbS Market Size by Application 9.3.1 Latin America Bi-Specific MAbS Market Size by Application (2016-2021) 9.3.2 Latin America Bi-Specific MAbS Market Size by Application (2022-2027) 9.3.3 Latin America Bi-Specific MAbS Market Size by Application (2016-2027) 9.4 Latin America Bi-Specific MAbS Market Size by Country 9.4.1 Latin America Bi-Specific MAbS Market Size by Country (2016-2021) 9.4.2 Latin America Bi-Specific MAbS Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Bi-Specific MAbS Market Size (2016-2027) 10.2 Middle East & Africa Bi-Specific MAbS Market Size by Type 10.2.1 Middle East & Africa Bi-Specific MAbS Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Bi-Specific MAbS Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Bi-Specific MAbS Market Size by Type (2016-2027) 10.3 Middle East & Africa Bi-Specific MAbS Market Size by Application 10.3.1 Middle East & Africa Bi-Specific MAbS Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Bi-Specific MAbS Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Bi-Specific MAbS Market Size by Application (2016-2027) 10.4 Middle East & Africa Bi-Specific MAbS Market Size by Country 10.4.1 Middle East & Africa Bi-Specific MAbS Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Bi-Specific MAbS Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Johnson and Johnson 11.1.1 Johnson and Johnson Company Details 11.1.2 Johnson and Johnson Business Overview 11.1.3 Johnson and Johnson Bi-Specific MAbS Introduction 11.1.4 Johnson and Johnson Revenue in Bi-Specific MAbS Business (2016-2021) 11.1.5 Johnson and Johnson Recent Development 11.2 Novartis AG 11.2.1 Novartis AG Company Details 11.2.2 Novartis AG Business Overview 11.2.3 Novartis AG Bi-Specific MAbS Introduction 11.2.4 Novartis AG Revenue in Bi-Specific MAbS Business (2016-2021) 11.2.5 Novartis AG Recent Development 11.3 Hoffmann-La Roche Ltd. 11.3.1 Hoffmann-La Roche Ltd. Company Details 11.3.2 Hoffmann-La Roche Ltd. Business Overview 11.3.3 Hoffmann-La Roche Ltd. Bi-Specific MAbS Introduction 11.3.4 Hoffmann-La Roche Ltd. Revenue in Bi-Specific MAbS Business (2016-2021) 11.3.5 Hoffmann-La Roche Ltd. Recent Development 11.4 Chugai Pharmaceutical 11.4.1 Chugai Pharmaceutical Company Details 11.4.2 Chugai Pharmaceutical Business Overview 11.4.3 Chugai Pharmaceutical Bi-Specific MAbS Introduction 11.4.4 Chugai Pharmaceutical Revenue in Bi-Specific MAbS Business (2016-2021) 11.4.5 Chugai Pharmaceutical Recent Development 11.5 Bayer AG 11.5.1 Bayer AG Company Details 11.5.2 Bayer AG Business Overview 11.5.3 Bayer AG Bi-Specific MAbS Introduction 11.5.4 Bayer AG Revenue in Bi-Specific MAbS Business (2016-2021) 11.5.5 Bayer AG Recent Development 11.6 Thermo Fisher Scientific 11.6.1 Thermo Fisher Scientific Company Details 11.6.2 Thermo Fisher Scientific Business Overview 11.6.3 Thermo Fisher Scientific Bi-Specific MAbS Introduction 11.6.4 Thermo Fisher Scientific Revenue in Bi-Specific MAbS Business (2016-2021) 11.6.5 Thermo Fisher Scientific Recent Development 11.7 Bistro-Myers Squibb 11.7.1 Bistro-Myers Squibb Company Details 11.7.2 Bistro-Myers Squibb Business Overview 11.7.3 Bistro-Myers Squibb Bi-Specific MAbS Introduction 11.7.4 Bistro-Myers Squibb Revenue in Bi-Specific MAbS Business (2016-2021) 11.7.5 Bistro-Myers Squibb Recent Development 11.8 Mylan N.V. 11.8.1 Mylan N.V. Company Details 11.8.2 Mylan N.V. Business Overview 11.8.3 Mylan N.V. Bi-Specific MAbS Introduction 11.8.4 Mylan N.V. Revenue in Bi-Specific MAbS Business (2016-2021) 11.8.5 Mylan N.V. Recent Development 11.9 Daiichi Sankyo Company 11.9.1 Daiichi Sankyo Company Company Details 11.9.2 Daiichi Sankyo Company Business Overview 11.9.3 Daiichi Sankyo Company Bi-Specific MAbS Introduction 11.9.4 Daiichi Sankyo Company Revenue in Bi-Specific MAbS Business (2016-2021) 11.9.5 Daiichi Sankyo Company Recent Development 11.10 Abbott 11.10.1 Abbott Company Details 11.10.2 Abbott Business Overview 11.10.3 Abbott Bi-Specific MAbS Introduction 11.10.4 Abbott Revenue in Bi-Specific MAbS Business (2016-2021) 11.10.5 Abbott Recent Development 11.11 AstraZeneca 11.11.1 AstraZeneca Company Details 11.11.2 AstraZeneca Business Overview 11.11.3 AstraZeneca Bi-Specific MAbS Introduction 11.11.4 AstraZeneca Revenue in Bi-Specific MAbS Business (2016-2021) 11.11.5 AstraZeneca Recent Development 11.12 Eli Lilly 11.12.1 Eli Lilly Company Details 11.12.2 Eli Lilly Business Overview 11.12.3 Eli Lilly Bi-Specific MAbS Introduction 11.12.4 Eli Lilly Revenue in Bi-Specific MAbS Business (2016-2021) 11.12.5 Eli Lilly Recent Development 11.13 Merck and Co. 11.13.1 Merck and Co. Company Details 11.13.2 Merck and Co. Business Overview 11.13.3 Merck and Co. Bi-Specific MAbS Introduction 11.13.4 Merck and Co. Revenue in Bi-Specific MAbS Business (2016-2021) 11.13.5 Merck and Co. Recent Development 11.14 Amgen 11.14.1 Amgen Company Details 11.14.2 Amgen Business Overview 11.14.3 Amgen Bi-Specific MAbS Introduction 11.14.4 Amgen Revenue in Bi-Specific MAbS Business (2016-2021) 11.14.5 Amgen Recent Development 11.15 Pfizer 11.15.1 Pfizer Company Details 11.15.2 Pfizer Business Overview 11.15.3 Pfizer Bi-Specific MAbS Introduction 11.15.4 Pfizer Revenue in Bi-Specific MAbS Business (2016-2021) 11.15.5 Pfizer Recent Development 11.16 GlaxoSmithKline plc 11.16.1 GlaxoSmithKline plc Company Details 11.16.2 GlaxoSmithKline plc Business Overview 11.16.3 GlaxoSmithKline plc Bi-Specific MAbS Introduction 11.16.4 GlaxoSmithKline plc Revenue in Bi-Specific MAbS Business (2016-2021) 11.16.5 GlaxoSmithKline plc Recent Development 11.17 Roche 11.17.1 Roche Company Details 11.17.2 Roche Business Overview 11.17.3 Roche Bi-Specific MAbS Introduction 11.17.4 Roche Revenue in Bi-Specific MAbS Business (2016-2021) 11.17.5 Roche Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

Tables & Figures

List of Tables Table 1. Global Bi-Specific MAbS Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Catumaxomab Table 3. Key Players of Blinatumomab Table 4. Key Players of Duligotumab Table 5. Key Players of SAR 156597 Table 6. Global Bi-Specific MAbS Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Bi-Specific MAbS Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Bi-Specific MAbS Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Bi-Specific MAbS Market Share by Regions (2016-2021) Table 10. Global Bi-Specific MAbS Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Bi-Specific MAbS Market Share by Regions (2022-2027) Table 12. Bi-Specific MAbS Market Trends Table 13. Bi-Specific MAbS Market Drivers Table 14. Bi-Specific MAbS Market Challenges Table 15. Bi-Specific MAbS Market Restraints Table 16. Global Bi-Specific MAbS Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Bi-Specific MAbS Market Share by Players (2016-2021) Table 18. Global Top Bi-Specific MAbS Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bi-Specific MAbS as of 2020) Table 19. Ranking of Global Top Bi-Specific MAbS Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Bi-Specific MAbS Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Bi-Specific MAbS Product Solution and Service Table 23. Date of Enter into Bi-Specific MAbS Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Bi-Specific MAbS Market Size by Type (2016-2021) (US$ Million) Table 26. Global Bi-Specific MAbS Revenue Market Share by Type (2016-2021) Table 27. Global Bi-Specific MAbS Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Bi-Specific MAbS Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Bi-Specific MAbS Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Bi-Specific MAbS Revenue Market Share by Application (2016-2021) Table 31. Global Bi-Specific MAbS Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Bi-Specific MAbS Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Bi-Specific MAbS Market Size by Type (2016-2021) (US$ Million) Table 34. North America Bi-Specific MAbS Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Bi-Specific MAbS Market Size by Application (2016-2021) (US$ Million) Table 36. North America Bi-Specific MAbS Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Bi-Specific MAbS Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Bi-Specific MAbS Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Bi-Specific MAbS Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Bi-Specific MAbS Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Bi-Specific MAbS Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Bi-Specific MAbS Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Bi-Specific MAbS Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Bi-Specific MAbS Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Bi-Specific MAbS Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Bi-Specific MAbS Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Bi-Specific MAbS Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Bi-Specific MAbS Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Bi-Specific MAbS Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Bi-Specific MAbS Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Bi-Specific MAbS Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Bi-Specific MAbS Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Bi-Specific MAbS Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Bi-Specific MAbS Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Bi-Specific MAbS Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Bi-Specific MAbS Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Bi-Specific MAbS Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Bi-Specific MAbS Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Bi-Specific MAbS Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Bi-Specific MAbS Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Bi-Specific MAbS Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Bi-Specific MAbS Market Size by Country (2022-2027) & (US$ Million) Table 63. Johnson and Johnson Company Details Table 64. Johnson and Johnson Business Overview Table 65. Johnson and Johnson Bi-Specific MAbS Product Table 66. Johnson and Johnson Revenue in Bi-Specific MAbS Business (2016-2021) & (US$ Million) Table 67. Johnson and Johnson Recent Development Table 68. Novartis AG Company Details Table 69. Novartis AG Business Overview Table 70. Novartis AG Bi-Specific MAbS Product Table 71. Novartis AG Revenue in Bi-Specific MAbS Business (2016-2021) & (US$ Million) Table 72. Novartis AG Recent Development Table 73. Hoffmann-La Roche Ltd. Company Details Table 74. Hoffmann-La Roche Ltd. Business Overview Table 75. Hoffmann-La Roche Ltd. Bi-Specific MAbS Product Table 76. Hoffmann-La Roche Ltd. Revenue in Bi-Specific MAbS Business (2016-2021) & (US$ Million) Table 77. Hoffmann-La Roche Ltd. Recent Development Table 78. Chugai Pharmaceutical Company Details Table 79. Chugai Pharmaceutical Business Overview Table 80. Chugai Pharmaceutical Bi-Specific MAbS Product Table 81. Chugai Pharmaceutical Revenue in Bi-Specific MAbS Business (2016-2021) & (US$ Million) Table 82. Chugai Pharmaceutical Recent Development Table 83. Bayer AG Company Details Table 84. Bayer AG Business Overview Table 85. Bayer AG Bi-Specific MAbS Product Table 86. Bayer AG Revenue in Bi-Specific MAbS Business (2016-2021) & (US$ Million) Table 87. Bayer AG Recent Development Table 88. Thermo Fisher Scientific Company Details Table 89. Thermo Fisher Scientific Business Overview Table 90. Thermo Fisher Scientific Bi-Specific MAbS Product Table 91. Thermo Fisher Scientific Revenue in Bi-Specific MAbS Business (2016-2021) & (US$ Million) Table 92. Thermo Fisher Scientific Recent Development Table 93. Bistro-Myers Squibb Company Details Table 94. Bistro-Myers Squibb Business Overview Table 95. Bistro-Myers Squibb Bi-Specific MAbS Product Table 96. Bistro-Myers Squibb Revenue in Bi-Specific MAbS Business (2016-2021) & (US$ Million) Table 97. Bistro-Myers Squibb Recent Development Table 98. Mylan N.V. Company Details Table 99. Mylan N.V. Business Overview Table 100. Mylan N.V. Revenue in Bi-Specific MAbS Business (2016-2021) & (US$ Million) Table 101. Mylan N.V. Recent Development Table 102. Daiichi Sankyo Company Company Details Table 103. Daiichi Sankyo Company Business Overview Table 104. Daiichi Sankyo Company Bi-Specific MAbS Product Table 105. Daiichi Sankyo Company Revenue in Bi-Specific MAbS Business (2016-2021) & (US$ Million) Table 106. Daiichi Sankyo Company Recent Development Table 107. Abbott Company Details Table 108. Abbott Business Overview Table 109. Abbott Bi-Specific MAbS Product Table 110. Abbott Revenue in Bi-Specific MAbS Business (2016-2021) & (US$ Million) Table 111. Abbott Recent Development Table 112. AstraZeneca Company Details Table 113. AstraZeneca Business Overview Table 114. AstraZeneca Bi-Specific MAbS Product Table 115. AstraZeneca Revenue in Bi-Specific MAbS Business (2016-2021) & (US$ Million) Table 116. AstraZeneca Recent Development Table 117. Eli Lilly Company Details Table 118. Eli Lilly Business Overview Table 119. Eli Lilly Bi-Specific MAbS Product Table 120. Eli Lilly Revenue in Bi-Specific MAbS Business (2016-2021) & (US$ Million) Table 121. Eli Lilly Recent Development Table 122. Merck and Co. Company Details Table 123. Merck and Co. Business Overview Table 124. Merck and Co. Bi-Specific MAbS Product Table 125. Merck and Co. Revenue in Bi-Specific MAbS Business (2016-2021) & (US$ Million) Table 126. Merck and Co. Recent Development Table 127. Amgen Company Details Table 128. Amgen Business Overview Table 129. Amgen Bi-Specific MAbS Product Table 130. Amgen Revenue in Bi-Specific MAbS Business (2016-2021) & (US$ Million) Table 131. Amgen Recent Development Table 132. Pfizer Company Details Table 133. Pfizer Business Overview Table 134. Pfizer Bi-Specific MAbS Product Table 135. Pfizer Revenue in Bi-Specific MAbS Business (2016-2021) & (US$ Million) Table 136. Pfizer Recent Development Table 137. GlaxoSmithKline plc Company Details Table 138. GlaxoSmithKline plc Business Overview Table 139. GlaxoSmithKline plc Bi-Specific MAbS Product Table 140. GlaxoSmithKline plc Revenue in Bi-Specific MAbS Business (2016-2021) & (US$ Million) Table 141. GlaxoSmithKline plc Recent Development Table 142. Roche Company Details Table 143. Roche Business Overview Table 144. Roche Bi-Specific MAbS Product Table 145. Roche Revenue in Bi-Specific MAbS Business (2016-2021) & (US$ Million) Table 146. Roche Recent Development Table 147. Research Programs/Design for This Report Table 148. Key Data Information from Secondary Sources Table 149. Key Data Information from Primary Sources List of Figures Figure 1. Global Bi-Specific MAbS Market Share by Type: 2020 VS 2027 Figure 2. Catumaxomab Features Figure 3. Blinatumomab Features Figure 4. Duligotumab Features Figure 5. SAR 156597 Features Figure 6. Global Bi-Specific MAbS Market Share by Application: 2020 VS 2027 Figure 7. Cancer Case Studies Figure 8. Autoimmune Diseases Case Studies Figure 9. Inflammatory Diseases Case Studies Figure 10. Infectious Diseases Case Studies Figure 11. Microbial Diseases Case Studies Figure 12. Others Case Studies Figure 13. Bi-Specific MAbS Report Years Considered Figure 14. Global Bi-Specific MAbS Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 15. Global Bi-Specific MAbS Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 16. Global Bi-Specific MAbS Market Share by Regions: 2020 VS 2027 Figure 17. Global Bi-Specific MAbS Market Share by Regions (2022-2027) Figure 18. Global Bi-Specific MAbS Market Share by Players in 2020 Figure 19. Global Top Bi-Specific MAbS Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bi-Specific MAbS as of 2020 Figure 20. The Top 10 and 5 Players Market Share by Bi-Specific MAbS Revenue in 2020 Figure 21. Global Bi-Specific MAbS Revenue Market Share by Type (2016-2021) Figure 22. Global Bi-Specific MAbS Revenue Market Share by Type (2022-2027) Figure 23. North America Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. North America Bi-Specific MAbS Market Share by Type (2016-2027) Figure 25. North America Bi-Specific MAbS Market Share by Application (2016-2027) Figure 26. North America Bi-Specific MAbS Market Share by Country (2016-2027) Figure 27. United States Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Canada Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Europe Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Europe Bi-Specific MAbS Market Share by Type (2016-2027) Figure 31. Europe Bi-Specific MAbS Market Share by Application (2016-2027) Figure 32. Europe Bi-Specific MAbS Market Share by Country (2016-2027) Figure 33. Germany Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. France Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. U.K. Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Italy Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Russia Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Nordic Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Asia-Pacific Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Asia-Pacific Bi-Specific MAbS Market Share by Type (2016-2027) Figure 41. Asia-Pacific Bi-Specific MAbS Market Share by Application (2016-2027) Figure 42. Asia-Pacific Bi-Specific MAbS Market Share by Region (2016-2027) Figure 43. China Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Japan Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. South Korea Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Southeast Asia Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. India Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Australia Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Latin America Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Latin America Bi-Specific MAbS Market Share by Type (2016-2027) Figure 51. Latin America Bi-Specific MAbS Market Share by Application (2016-2027) Figure 52. Latin America Bi-Specific MAbS Market Share by Country (2016-2027) Figure 53. Mexico Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Brazil Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Middle East & Africa Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Middle East & Africa Bi-Specific MAbS Market Share by Type (2016-2027) Figure 57. Middle East & Africa Bi-Specific MAbS Market Share by Application (2016-2027) Figure 58. Middle East & Africa Bi-Specific MAbS Market Share by Country (2016-2027) Figure 59. Turkey Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Saudi Arabia Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. UAE Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million) Figure 62. Johnson and Johnson Revenue Growth Rate in Bi-Specific MAbS Business (2016-2021) Figure 63. Novartis AG Revenue Growth Rate in Bi-Specific MAbS Business (2016-2021) Figure 64. Hoffmann-La Roche Ltd. Revenue Growth Rate in Bi-Specific MAbS Business (2016-2021) Figure 65. Chugai Pharmaceutical Revenue Growth Rate in Bi-Specific MAbS Business (2016-2021) Figure 66. Bayer AG Revenue Growth Rate in Bi-Specific MAbS Business (2016-2021) Figure 67. Thermo Fisher Scientific Revenue Growth Rate in Bi-Specific MAbS Business (2016-2021) Figure 68. Bistro-Myers Squibb Revenue Growth Rate in Bi-Specific MAbS Business (2016-2021) Figure 69. Mylan N.V. Revenue Growth Rate in Bi-Specific MAbS Business (2016-2021) Figure 70. Daiichi Sankyo Company Revenue Growth Rate in Bi-Specific MAbS Business (2016-2021) Figure 71. Abbott Revenue Growth Rate in Bi-Specific MAbS Business (2016-2021) Figure 72. AstraZeneca Revenue Growth Rate in Bi-Specific MAbS Business (2016-2021) Figure 73. Eli Lilly Revenue Growth Rate in Bi-Specific MAbS Business (2016-2021) Figure 74. Merck and Co. Revenue Growth Rate in Bi-Specific MAbS Business (2016-2021) Figure 75. Amgen Revenue Growth Rate in Bi-Specific MAbS Business (2016-2021) Figure 76. Pfizer Revenue Growth Rate in Bi-Specific MAbS Business (2016-2021) Figure 77. GlaxoSmithKline plc Revenue Growth Rate in Bi-Specific MAbS Business (2016-2021) Figure 78. Roche Revenue Growth Rate in Bi-Specific MAbS Business (2016-2021) Figure 79. Bottom-up and Top-down Approaches for This Report Figure 80. Data Triangulation Figure 81. Key Executives Interviewed

Companies

PRICE
$3900

$7800

$5850
Buy Now

Our Clients